The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Are The Forecasted Market Size Figures For The Whole Genome And Exome Sequencing Market In 2026 And 2030?
The whole genome and exome sequencing market has witnessed exponential expansion in recent years. It is anticipated to increase from $2.52 billion in 2025 to $3.14 billion in 2026, achieving a compound annual growth rate (CAGR) of 24.8%. The historical growth of this market can be credited to factors such as advancements in next-generation sequencing technologies, the expanding utilization of genomics in cancer research, the growth of academic genomics initiatives, decreasing sequencing expenses, and the development of precision medicine programs.
The whole genome and exome sequencing market size is anticipated to experience significant expansion in the upcoming years. This market is forecasted to reach $7.63 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 24.8%. The growth during this forecast period is attributable to the increasing deployment of large-scale genomics projects, the rising integration of AI in genomic analysis, the expansion of clinical genomics adoption, growing investments in sequencing infrastructure, and an increasing demand for personalized treatment strategies. Key trends for the forecast period include the increasing adoption of comprehensive genome sequencing, the rising use of sequencing in oncology diagnostics, a growing demand for integrated wgs and wes workflows, the expansion of population genomics studies, and an enhanced focus on high-throughput sequencing platforms.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp
Which Strategic Drivers Are Supporting The Whole Genome And Exome Sequencing Market Development?
The increasing need for personalized medicine is anticipated to drive expansion in the whole genome and exome sequencing market going forward. This medical treatment strategy customizes healthcare choices and interventions for each patient based on their unique attributes, encompassing genetics, environmental influences, and lifestyle choices. In personalized medicine, whole genome and exome sequencing offers a thorough examination of a person’s genetic profile, enabling customized healthcare decisions and interventions aligned with their specific genetic, environmental, and lifestyle elements. As an example, in February 2024, the Personalized Medicine Coalition (PMC), a US organization advocating for personalized medicine, reported that the FDA approved 26 personalized medicines. These included 20 new molecular entities (NMEs) and 6 gene-/cell-based therapies, together accounting for approximately 38% of all recently approved therapeutic NMEs. Consequently, the growing demand for personalized medicine is fueling the expansion of the whole genome and exome sequencing market.
Which Segment Divisions Form The Structure Of The Whole Genome And Exome Sequencing Market?
The whole genome and exome sequencing market covered in this report is segmented –
1) By Product Type: Kits, Instruments
2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)
3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications
4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Kits: Library Preparation Kits, Target Enrichment Kits, DNA Extraction Kits
2) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Third-Generation Sequencing Systems
What Trends Are Affecting The Growth Of The Whole Genome And Exome Sequencing Market?
Major companies operating in the whole exome sequencing market are developing advanced next-generation sequencing (NGS) ultra-fast technology to improve the speed and precision of genetic analysis, thus enabling faster diagnostics and personalized treatment plans in healthcare. Next-generation sequencing (NGS) ultra-fast technology enhances whole exome sequencing by rapidly analyzing exonic areas, facilitating the swift detection of genetic mutations crucial for diagnosis and research. For instance, in January 2023, Qiagen, a Germany-based medical devices and health care company, launched the CLC genomics workbench premium with lightspeed technology, allowing for efficient analysis of whole genome sequencing (WGS) and whole exome sequencing (WES) data. This innovation processes an entire genome in just 25 minutes for about $1 using cloud computing, while also providing support for local hardware. By reducing time and costs, lightSpeed enhances the accessibility of large-scale genetic testing in the WES market.
Which Companies Are Engaged In The Whole Genome And Exome Sequencing Market Environment?
Major companies operating in the whole genome and exome sequencing market are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V, BGI Genomics, Novogene Co., Oxford Nanopore Technologies Inc., Pacific Biosciences of California Inc., GENEWIZ Inc., 10x Genomics Inc., MGI Tech Co. Ltd., Clear Labs Inc., Macrogen Inc., PierianDx Inc., Invitae Corporation, Fulgent Genetics Inc., SOPHiA GENETICS SA, Azenta US Inc., Gene by Gene Ltd.
Access The Complete Whole Genome And Exome Sequencing Market Report:
Which Region Leads The Whole Genome And Exome Sequencing Market By Size?
North America was the largest region in the whole genome and exome sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Whole Genome And Exome Sequencing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=13957&type=smp
Browse Through More Reports Similar to the Global Whole Genome And Exome Sequencing Market 2026, By The Business Research Company
Whole Exome Sequencing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report
Next Generation Sequencing Market 2026
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market
Dna Sequencing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model